What underlies the diversity of brain tumors?

Cancer and Metastasis Reviews

Volumn 32, Issue 1-2, 2013, Pages 5-24

  Swartling, Fredrik J ^a   Hede, Sanna Maria ^a   Weiss, William A ^b,c,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Development; Glioma; Medulloblastoma; Murine model; Transgene

Indexed keywords

GROWTH FACTOR; WNT PROTEIN;

ARTICLE; ASTROCYTOMA; BRAIN DEVELOPMENT; BRAIN TUMOR; CANCER PROGNOSIS; EMBRYO DEVELOPMENT; FOREBRAIN; GENETIC ENGINEERING; GLIOBLASTOMA; GLIOMA; HUMAN; METASTASIS; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIOMA; ONCOGENE; PRIORITY JOURNAL; RHOMBENCEPHALON; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 84878114730     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9407-3     Document Type: Article

References (197)

1. Lumsden, A., & Krumlauf, R. (1996). Patterning the vertebrate neuraxis. Science, 274(5290), 1109-1115.
2. Liu, A., & Niswander, L. A. (2005). Bone morphogenetic protein signalling and vertebrate nervous system development. Nature Reviews Neuroscience, 6(12), 945-954.
3. Rowitch, D. H., & Kriegstein, A. R. (2010). Developmental genetics of vertebrate glial-cell specification. Nature, 468(7321), 214-222.
4. Malatesta, P., Hartfuss, E., & Gotz, M. (2000). Isolation of radial glial cells by fluorescent-activated cell sorting reveals a neuronal lineage. Development, 127(24), 5253-5263.
5. Hansen, D. V., Lui, J. H., Parker, P. R., & Kriegstein, A. R. (2010). Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature, 464(7288), 554-561.
6. Feng, L., Hatten, M. E., & Heintz, N. (1994). Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron, 12(4), 895-908.
7. Hartfuss, E., Galli, R., Heins, N., & Gotz, M. (2001). Characterization of CNS precursor subtypes and radial glia. Developmental Biology, 229(1), 15-30.
8. Kurtz, A., Zimmer, A., Schnutgen, F., Bruning, G., Spener, F., & Muller, T. (1994). The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development, 120(9), 2637-2649.
9. Anthony, T. E., Klein, C., Fishell, G., & Heintz, N. (2004). Radial glia serve as neuronal progenitors in all regions of the central nervous system. Neuron, 41(6), 881-890.
10. Noble, M. (2000). Precursor cell transitions in oligodendrocyte development. The Journal of Cell Biology, 148(5), 839-842.
11. Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006). Origin of oligodendrocytes in the subventricular zone of the adult brain. The Journal of Neuroscience, 26(30), 7907-7918.
12. Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1999). Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell, 97(6), 703-716.
13. Eriksson, P. S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., et al. (1998). Neurogenesis in the adult human hippocampus. Nature Medicine, 4(11), 1313-1317.
14. Kriegstein, A., & Alvarez-Buylla, A. (2009). The glial nature of embryonic and adult neural stem cells. Annual Review of Neuroscience, 32, 149-184.
15. Spassky, N., Merkle, F. T., Flames, N., Tramontin, A. D., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (2005). Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. The Journal of Neuroscience, 25(1), 10-18.
16. Sgaier, S. K., Millet, S., Villanueva, M. P., Berenshteyn, F., Song, C., & Joyner, A. L. (2005). Morphogenetic and cellular movements that shape the mouse cerebellum; insights from genetic fate mapping. Neuron, 45(1), 27-40.
17. Simeone, A. (2000). Positioning the isthmic organizer where Otx2 and Gbx2meet. Trends in Genetics, 16(6), 237-240.
18. Joyner, A. L., Liu, A., & Millet, S. (2000). Otx2, Gbx2 and Fgf8 interact to position and maintain a mid-hindbrain organizer. Current Opinion in Cell Biology, 12(6), 736-741.
19. Ito, M. (2008). Control of mental activities by internal models in the cerebellum. Nature Reviews Neuroscience, 9(4), 304-313.
20. Levisohn, L., Cronin-Golomb, A., & Schmahmann, J. D. (2000). Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain, 123(Pt 5), 1041-1050.
21. Hatten, M. E., & Heintz, N. (1995). Mechanisms of neural patterning and specification in the developing cerebellum. Annual Review of Neuroscience, 18, 385-408.
22. Hoshino, M., Nakamura, S., Mori, K., Kawauchi, T., Terao, M., Nishimura, Y. V., et al. (2005). Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum. Neuron, 47(2), 201-213.
23. Pascual, M., Abasolo, I., Mingorance-Le Meur, A., Martinez, A., Del Rio, J. A., Wright, C. V., et al. (2007). Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expression. Proceedings of the National Academy of Sciences of the United States of America, 104(12), 5193-5198.
24. Edwards, M. A., Yamamoto, M., & Caviness, V. S., Jr. (1990). Organization of radial glia and related cells in the developing murine CNS. An analysis based upon a new monoclonal antibody marker. Neuroscience, 36(1), 121-144.
25. Morales, D., & Hatten, M. E. (2006). Molecular markers of neuronal progenitors in the embryonic cerebellar anlage. The Journal of Neuroscience, 26(47), 12226-12236.
26. Hevner, R. F., Hodge, R. D., Daza, R. A., & Englund, C. (2006). Transcription factors in glutamatergic neurogenesis: conserved programs in neocortex, cerebellum, and adult hippocampus. Neuroscience Research, 55(3), 223-233.
27. Akazawa, C., Ishibashi, M., Shimizu, C., Nakanishi, S., & Kageyama, R. (1995). A mammalian helix-loop-helix factor structurally related to the product of Drosophila proneural gene atonal is a positive transcriptional regulator expressed in the developing nervous system. The Journal of Biological Chemistry, 270(15), 8730-8738.
28. Ben-Arie, N., Bellen, H. J., Armstrong, D. L., McCall, A. E., Gordadze, P. R., Guo, Q., et al. (1997). Math1 is essential for genesis of cerebellar granule neurons. Nature, 390(6656), 169-172.
29. Altman, J., & Bayer, S. A. (1997). Development of the cerebellar system: In relation to its evolution, structure and functions. Boca Raton: CRC Press.
30. Wechsler-Reya, R. J., & Scott, M. P. (1999). Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron, 22(1), 103-114.
31. Dahmane, N., & Ruiz i Altaba, A. (1999). Sonic hedgehog regulates the growth and patterning of the cerebellum. Development, 126(14), 3089-3100.
32. Huang, X., Liu, J., Ketova, T., Fleming, J. T., Grover, V. K., Cooper, M. K., et al. (2010). Transventricular delivery of Sonic hedgehog is essential to cerebellar ventricular zone development. Proceedings of the National Academy of Sciences of the United States of America, 107(18), 8422-8427.
33. Machold, R., & Fishell, G. (2005). Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors. Neuron, 48(1), 17-24.
34. Wang, V. Y., Rose, M. F., & Zoghbi, H. Y. (2005). Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum. Neuron, 48(1), 31-43.
35. Zhuo, L., Theis, M., Alvarez-Maya, I., Brenner, M., Willecke, K., & Messing, A. (2001). hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis, 31(2), 85-94.
36. Schuller, U., Heine, V. M., Mao, J., Kho, A. T., Dillon, A. K., Han, Y. G., et al. (2008). Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell, 14(2), 123-134.
37. Yang, Z. J., Ellis, T., Markant, S. L., Read, T. A., Kessler, J. D., Bourboulas, M., et al. (2008). Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell, 14(2), 135-145.
38. Aldinger, K. A., & Elsen, G. E. (2008). Ptf1a is a molecular determinant for both glutamatergic and GABAergic neurons in the hindbrain. The Journal of Neuroscience, 28(2), 338-339.
39. Raaf, J., & Kernohan, J. (1944). A study of the external granular layer in the cerebellum. The American Journal of Anatomy, 75, 151-172.
40. Chizhikov, V. V., Lindgren, A. G., Currle, D. S., Rose, M. F., Monuki, E. S., & Millen, K. J. (2006). The roof plate regulates cerebellar cell-type specification and proliferation. Development, 133(15), 2793-2804.
41. Machold, R. P., Kittell, D. J., & Fishell, G. J. (2007). Antagonism between Notch and bone morphogenetic protein receptor signaling regulates neurogenesis in the cerebellar rhombic lip. Neural Development, 2, 5.
42. Alder, J., Lee, K. J., Jessell, T. M., & Hatten, M. E. (1999). Generation of cerebellar granule neurons in vivo by transplantation of BMP-treated neural progenitor cells. Nature Neuroscience, 2(6), 535-540.
43. Rios, I., Alvarez-Rodriguez, R., Marti, E., & Pons, S. (2004). Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development, 131(13), 3159-3168.
44. Zhao, H., Ayrault, O., Zindy, F., Kim, J. H., & Roussel, M. F. (2008). Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes & Development, 22(6), 722-727.
45. Lutolf, S., Radtke, F., Aguet, M., Suter, U., & Taylor, V. (2002). Notch1 is required for neuronal and glial differentiation in the cerebellum. Development, 129(2), 373-385.
46. Solecki, D. J., Liu, X. L., Tomoda, T., Fang, Y., & Hatten, M. E. (2001). Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron, 31(4), 557-568.
47. Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., et al. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology, 10(5), 459-466.
48. Cairncross, J. G., Ueki, K., Zlatescu, M. C., Lisle, D. K., Finkelstein, D. M., Hammond, R. R., et al. (1998). Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. Journal of the National Cancer Institute, 90(19), 1473-1479.
49. Cancer Genome Atlas Research Network. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455(7216), 1061-1068.
50. Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9(3), 157-173.
51. Verhaak, R. G., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., et al. (2010). Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17(1), 98-110.
52. Lai, A., Kharbanda, S., Pope, W. B., Tran, A., Solis, O. E., Peale, F., et al. (2011). Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. Journal of Clinical Oncology, 29(34), 4482-4490.
53. Pfister, S., Janzarik, W. G., Remke, M., Ernst, A., Werft, W., Becker, N., et al. (2008). BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. The Journal of Clinical Investigation, 118(5), 1739-1749.
54. Jones, D. T., Kocialkowski, S., Liu, L., Pearson, D. M., Backlund, L. M., Ichimura, K., et al. (2008). Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Research, 68(21), 8673-8677.
55. Lewis, R. A., Gerson, L. P., Axelson, K. A., Riccardi, V. M., & Whitford, R. P. (1984). von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology, 91(8), 929-935.
56. Schwartzentruber, J., Korshunov, A., Liu, X. Y., Jones, D. T., Pfaff, E., Jacob, K., et al. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482(7384), 226-231.
57. Johnson, R. A., Wright, K. D., Poppleton, H., Mohankumar, K. M., Finkelstein, D., Pounds, S. B., et al. (2010). Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature, 466(7306), 632-636.
58. Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., et al. (1992). Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proceedings of the National Academy of Sciences of the United States of America, 89(7), 2965-2969.
59. Ekstrand, A. J., Longo, N., Hamid, M. L., Olson, J. J., Liu, L., Collins, V. P., et al. (1994). Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene, 9(8), 2313-2320.
60. Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998). A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes & Development, 12(23), 3675-3685.
61. Weiss, W. A., Burns, M. J., Hackett, C., Aldape, K., Hill, J. R., Kuriyama, H., et al. (2003). Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Research, 63(7), 1589-1595.
62. Ding, H., Shannon, P., Lau, N., Wu, X., Roncari, L., Baldwin, R. L., et al. (2003). Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Research, 63(5), 1106-1113.
63. Persson, A. I., Petritsch, C., Swartling, F. J., Itsara, M., Sim, F. J., Auvergne, R., et al. (2010). Non-stem cell origin for oligodendroglioma. Cancer Cell, 18(6), 669-682.
64. Bachoo, R. M., Maher, E. A., Ligon, K. L., Sharpless, N. E., Chan, S. S., You, M. J., et al. (2002). Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell, 1(3), 269-277.
65. Zhu, H., Acquaviva, J., Ramachandran, P., Boskovitz, A., Woolfenden, S., Pfannl, R., et al. (2009). Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America, 106(8), 2712-2716.
66. Acquaviva, J., Jun, H. J., Lessard, J., Ruiz, R., Zhu, H., Donovan, M., et al. (2011). Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation. Cancer Research, 71(23), 7198-7206.
67. Fleming, T. P., Saxena, A., Clark, W. C., Robertson, J. T., Oldfield, E. H., Aaronson, S. A., et al. (1992). Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Research, 52(16), 4550-4553.
68. Hermanson, M., Funa, K., Hartman, M., Claesson-Welsh, L., Heldin, C. H., Westermark, B., et al. (1992). Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Research, 52(11), 3213-3219.
69. Calzolari, F., Appolloni, I., Tutucci, E., Caviglia, S., Terrile, M., Corte, G., et al. (2008). Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis. Neoplasia, 10(12), 1373-1382. following 1382.
70. Uhrbom, L., Hesselager, G., Nister, M., & Westermark, B. (1998). Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Research, 58(23), 5275-5279.
71. Assanah, M. C., Bruce, J. N., Suzuki, S. O., Chen, A., Goldman, J. E., & Canoll, P. (2009). PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia, 57(16), 1835-1847.
72. Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., & Holland, E. C. (2001). PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes & Development, 15(15), 1913-1925.
73. Lindberg, N., Kastemar, M., Olofsson, T., Smits, A., & Uhrbom, L. (2009). Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene, 28(23), 2266-2275.
74. Hesselager, G., Uhrbom, L., Westermark, B., & Nister, M. (2003). Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Research, 63(15), 4305-4309.
75. Tchougounova, E., Kastemar, M., Brasater, D., Holland, E. C., Westermark, B., & Uhrbom, L. (2007). Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene, 26(43), 6289-6296.
76. Hede, S. M., Hansson, I., Afink, G. B., Eriksson, A., Nazarenko, I., Andrae, J., et al. (2009). GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background. Glia, 57(11), 1143-1153.
77. Nazarenko, I., Hedren, A., Sjodin, H., Orrego, A., Andrae, J., Afink, G. B., et al. (2011). Brain abnormalities and glioma-like lesions in mice overexpressing the long isoform of PDGF-A in astrocytic cells. PloS One, 6(4), e18303.
78. Lei, L., Sonabend, A. M., Guarnieri, P., Soderquist, C., Ludwig, T., Rosenfeld, S., et al. (2011). Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PloS One, 6(5), e20041.
79. Ding, H., Roncari, L., Shannon, P., Wu, X., Lau, N., Karaskova, J., et al. (2001). Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Research, 61(9), 3826-3836.
80. Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., & Fuller, G. N. (2000). Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genetics, 25(1), 55-57.
81. Uhrbom, L., Dai, C., Celestino, J. C., Rosenblum, M. K., Fuller, G. N., & Holland, E. C. (2002). Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Research, 62(19), 5551-5558.
82. Marumoto, T., Tashiro, A., Friedmann-Morvinski, D., Scadeng, M., Soda, Y., Gage, F. H., et al. (2009). Development of a novel mouse glioma model using lentiviral vectors. Nature Medicine, 15(1), 110-116.
83. Reilly, K. M., Loisel, D. A., Bronson, R. T., McLaughlin, M. E., & Jacks, T. (2000). Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nature Genetics, 26(1), 109-113.
84. Wang, Y., Yang, J., Zheng, H., Tomasek, G. J., Zhang, P., McKeever, P. E., et al. (2009). Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell, 15(6), 514-526.
85. Zhu, Y., Guignard, F., Zhao, D., Liu, L., Burns, D. K., Mason, R. P., et al. (2005). Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell, 8(2), 119-130.
86. von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., et al. (1992). p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Research, 52(10), 2987-2990.
87. Kwon, C. H., Zhao, D., Chen, J., Alcantara, S., Li, Y., Burns, D. K., et al. (2008). Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Research, 68(9), 3286-3294.
88. Alcantara Llaguno, S., Chen, J., Kwon, C. H., Jackson, E. L., Li, Y., Burns, D. K., et al. (2009). Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell, 15(1), 45-56.
89. Jacques, T. S., Swales, A., Brzozowski, M. J., Henriquez, N. V., Linehan, J. M., Mirzadeh, Z., et al. (2010). Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. The EMBO Journal, 29(1), 222-235.
90. Chow, L. M., Endersby, R., Zhu, X., Rankin, S., Qu, C., Zhang, J., et al. (2011). Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell, 19(3), 305-316.
91. Gronych, J., Korshunov, A., Bageritz, J., Milde, T., Jugold, M., Hambardzumyan, D., et al. (2011). An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. The Journal of Clinical Investigation, 121(4), 1344-1348.
92. Becher, O. J., Hambardzumyan, D., Walker, T. R., Helmy, K., Nazarian, J., Albrecht, S., et al. (2010). Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Research, 70(6), 2548-2557.
93. Hitoshi, Y., Harris, B. T., Liu, H., Popko, B., & Israel, M. A. (2008). Spinal glioma: platelet-derived growth factor B-mediated oncogenesis in the spinal cord. Cancer Research, 68(20), 8507-8515.
94. Liu, C., Sage, J. C., Miller, M. R., Verhaak, R. G., Hippenmeyer, S., Vogel, H., et al. (2011). Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell, 146(2), 209-221.
95. Hambardzumyan, D., Amankulor, N. M., Helmy, K. Y., Becher, O. J., & Holland, E. C. (2009). Modeling adult gliomas using RCAS/t-va technology. Translational Oncology, 2(2), 89-95.
96. Taylor, M. D., Poppleton, H., Fuller, C., Su, X., Liu, Y., Jensen, P., et al. (2005). Radial glia cells are candidate stem cells of ependymoma. Cancer Cell, 8(4), 323-335.
97. Saran, A. (2009). Medulloblastoma: role of developmental pathways, DNA repair signaling, and other players. Current Molecular Medicine, 9(9), 1046-1057.
98. Schmidt, A. L., Brunetto, A. L., Schwartsmann, G., Roesler, R., & Abujamra, A. L. (2010). Recent therapeutic advances for treating medulloblastoma: focus on new molecular targets. CNS & Neurological Disorders Drug Targets, 9(3), 335-348.
99. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica, 114(2), 97-109.
100. Eberhart, C. G., Brat, D. J., Cohen, K. J., & Burger, P. C. (2000). Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatric and Developmental Pathology, 3(4), 346-352.
101. Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y. J., Clifford, S. C., et al. (2011). Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathology, 123(4), 465-472.
102. Thompson, M. C., Fuller, C., Hogg, T. L., Dalton, J., Finkelstein, D., Lau, C. C., et al. (2006). Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Journal of Clinical Oncology, 24(12), 1924-1931.
103. Kool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., et al. (2008). Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PloS One, 3(8), e3088.
104. Cho, Y. J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., et al. (2011). Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. Journal of Clinical Oncology, 29(11), 1424-1430.
105. Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., et al. (2011). Medulloblastoma comprises four distinct molecular variants. Journal of Clinical Oncology, 29(11), 1408-1414.
106. Kool, M., Korshunov, A., Remke, M., Jones, D. T., Schlanstein, M., Northcott, P. A., et al. (2012). Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathologica, 123(4), 473-484.
107. Nusslein-Volhard, C., & Wieschaus, E. (1980). Mutations affecting segment number and polarity in Drosophila. Nature, 287(5785), 795-801.
108. Espinosa, J. S., & Luo, L. (2008). Timing neurogenesis and differentiation: insights from quantitative clonal analyses of cerebellar granule cells. The Journal of Neuroscience, 28(10), 2301-2312.
109. Hahn, H., Wicking, C., Zaphiropoulous, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., et al. (1996). Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell, 85(6), 841-851.
110. Goodrich, L. V., Milenkovic, L., Higgins, K. M., & Scott, M. P. (1997). Altered neural cell fates and medulloblastoma in mouse patched mutants. Science, 277(5329), 1109-1113.
111. Pazzaglia, S., Mancuso, M., Atkinson, M. J., Tanori, M., Rebessi, S., Majo, V. D., et al. (2002). High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice. Oncogene, 21(49), 7580-7584.
112. Wetmore, C., Eberhart, D. E., & Curran, T. (2001). Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Research, 61(2), 513-516.
113. Hallahan, A. R., Pritchard, J. I., Hansen, S., Benson, M., Stoeck, J., Hatton, B. A., et al. (2004). The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Research, 64(21), 7794-7800.
114. Hatton, B. A., Villavicencio, E. H., Tsuchiya, K. D., Pritchard, J. I., Ditzler, S., Pullar, B., et al. (2008). The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Research, 68(6), 1768-1776.
115. Mao, J., Ligon, K. L., Rakhlin, E. Y., Thayer, S. P., Bronson, R. T., Rowitch, D., et al. (2006). A novel somatic mouse model to survey tumorigenic potential applied to the hedgehog pathway. Cancer Research, 66(20), 10171-10178.
116. Huangfu, D., & Anderson, K. V. (2005). Cilia and hedgehog responsiveness in the mouse. Proceedings of the National Academy of Sciences of the United States of America, 102(32), 11325-11330.
117. Rohatgi, R., Milenkovic, L., & Scott, M. P. (2007). Patched1 regulates hedgehog signaling at the primary cilium. Science, 317(5836), 372-376.
118. Corbit, K. C., Aanstad, P., Singla, V., Norman, A. R., Stainier, D. Y., & Reiter, J. F. (2005). Vertebrate smoothened functions at the primary cilium. Nature, 437(7061), 1018-1021.
119. Han, Y. G., Kim, H. J., Dlugosz, A. A., Ellison, D. W., Gilbertson, R. J., & Alvarez-Buylla, A. (2009). Dual and opposing roles of primary cilia in medulloblastoma development. Nature Medicine, 15(9), 1062-1065.
120. Weiner, H. L., Bakst, R., Hurlbert, M. S., Ruggiero, J., Ahn, E., Lee, W. S., et al. (2002). Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. Cancer Research, 62(22), 6385-6389.
121. Rao, G., Pedone, C. A., Coffin, C. M., Holland, E. C., & Fults, D. W. (2003). c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia, 5(3), 198-204.
122. Rao, G., Pedone, C. A., Del Valle, L., Reiss, K., Holland, E. C., & Fults, D. W. (2004). Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene, 23(36), 6156-6162.
123. Browd, S. R., Kenney, A. M., Gottfried, O. N., Yoon, J. W., Walterhouse, D., Pedone, C. A., et al. (2006). N-myc can substitute for insulin-like growth factor signaling in a mouse model of sonic hedgehog-induced medulloblastoma. Cancer Research, 66(5), 2666-2672.
124. Kenney, A. M., Cole, M. D., & Rowitch, D. H. (2003). Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development, 130(1), 15-28.
125. Kessler, J. D., Hasegawa, H., Brun, S. N., Yang, Z. J., Dutton, J. W., Wang, F., et al. (2009). N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma. Genes & Development, 23(2), 157-170.
126. Stecca, B., & Ruiz i Altaba, A. (2009). A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. The EMBO Journal, 28(6), 663-676.
127. Flora, A., Klisch, T. J., Schuster, G., & Zoghbi, H. Y. (2009). Deletion of Atoh1 disrupts sonic hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science, 326(5958), 1424-1427.
128. Lee, Y., Kawagoe, R., Sasai, K., Li, Y., Russell, H. R., Curran, T., et al. (2007). Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene, 26(44), 6442-6447.
129. Rausch, T., Jones, D. T., Zapatka, M., Stutz, A. M., Zichner, T., Weischenfeldt, J., et al. (2012). Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell, 148(1-2), 59-71.
130. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J., & Berns, A. (2000). Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes & Development, 14(8), 994-1004.
131. Tong, W. M., Ohgaki, H., Huang, H., Granier, C., Kleihues, P., & Wang, Z. Q. (2003). Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice. The American Journal of Pathology, 162(1), 343-352.
132. Lee, Y., & McKinnon, P. J. (2002). DNA ligase IV suppresses medulloblastoma formation. Cancer Research, 62(22), 6395-6399.
133. Frappart, P. O., Lee, Y., Russell, H. R., Chalhoub, N., Wang, Y. D., Orii, K. E., et al. (2009). Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency. Proceedings of the National Academy of Sciences of the United States of America, 106(6), 1880-1885.
134. Yan, C. T., Kaushal, D., Murphy, M., Zhang, Y., Datta, A., Chen, C., et al. (2006). XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 103(19), 7378-7383.
135. Nusse, R., van Ooyen, A., Cox, D., Fung, Y. K., & Varmus, H. (1984). Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature, 307(5947), 131-136.
136. Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., et al. (2011). Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathologica, 121(3), 381-396.
137. Gibson, P., Tong, Y., Robinson, G., Thompson, M. C., Currle, D. S., Eden, C., et al. (2010). Subtypes of medulloblastoma have distinct developmental origins. Nature, 468(7327), 1095-1099.
138. Korshunov, A., Remke, M., Kool, M., Hielscher, T., Northcott, P. A., Williamson, D., et al. (2011). Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. Acta Neuropathology, 123(4), 515-527.
139. Swartling, F. J., Grimmer, M. R., Hackett, C. S., Northcott, P. A., Fan, Q. W., Goldenberg, D. D., et al. (2010). Pleiotropic role for MYCN in medulloblastoma. Genes & Development, 24(10), 1059-1072.
140. Pei, Y., Moore, C. E., Wang, J., Tewari, A. K., Eroshkin, A., Cho, Y. J., et al. (2012). An animal model of MYC-driven medulloblastoma. Cancer Cell, 21(2), 155-167.
141. Kawauchi, D., Robinson, G., Uziel, T., Gibson, P., Rehg, J., Gao, C., et al. (2012). A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell, 21(2), 168-180.
142. Swartling, F. J., Savov, V., Persson, A. I., Chen, J., Hackett, C. S., Grimmer, M. R., et al. (2012). Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell, 25(5), 601-613.
143. Gajjar, A., Chintagumpala, M., Ashley, D., Kellie, S., Kun, L. E., Merchant, T. E., et al. (2006). Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. The Lancet Oncology, 7(10), 813-820.
144. von Hoff, K., Hinkes, B., Gerber, N. U., Deinlein, F., Mittler, U., Urban, C., et al. (2009). Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. European Journal of Cancer, 45(7), 1209-1217.
145. Wu, X., Northcott, P. A., Dubuc, A., Dupuy, A. J., Shih, D. J., Witt, H., et al. (2012). Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature, 482(7386), 529-533.
146. MacDonald, T. J., Brown, K. M., LaFleur, B., Peterson, K., Lawlor, C., Chen, Y., et al. (2001). Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nature Genetics, 29(2), 143-152.
147. Eibl, R. H., Kleihues, P., Jat, P. S., & Wiestler, O. D. (1994). A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. The American Journal of Pathology, 144(3), 556-564.
148. Theuring, F., Gotz, W., Balling, R., Korf, H. W., Schulze, F., Herken, R., et al. (1990). Tumorigenesis and eye abnormalities in transgenic mice expressing MSV-SV40 large T-antigen. Oncogene, 5(2), 225-232.
149. al-Ubaidi, M. R., Font, R. L., Quiambao, A. B., Keener, M. J., Liou, G. I., Overbeek, P. A., et al. (1992). Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. The Journal of Cell Biology, 119(6), 1681-1687.
150. Momota, H., Shih, A. H., Edgar, M. A., & Holland, E. C. (2008). c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice. Oncogene, 27(32), 4392-4401.
151. Perry, A., Miller, C. R., Gujrati, M., Scheithauer, B. W., Zambrano, S. C., Jost, S. C., et al. (2009). Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathology, 19(1), 81-90.
152. Biegel, J. A., Tan, L., Zhang, F., Wainwright, L., Russo, P., & Rorke, L. B. (2002). Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clinical Cancer Research, 8(11), 3461-3467.
153. Jagani, Z., Mora-Blanco, E. L., Sansam, C. G., McKenna, E. S., Wilson, B., Chen, D., et al. (2010). Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nature Medicine, 16(12), 1429-1433.
154. Guidi, C. J., Sands, A. T., Zambrowicz, B. P., Turner, T. K., Demers, D. A., Webster, W., et al. (2001). Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Molecular and Cellular Biology, 21(10), 3598-3603.
155. Roberts, C. W., Galusha, S. A., McMenamin, M. E., Fletcher, C. D., & Orkin, S. H. (2000). Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proceedings of the National Academy of Sciences of the United States of America, 97(25), 13796-13800.
156. Remke, M., Hielscher, T., Northcott, P. A., Witt, H., Ryzhova, M., Wittmann, A., et al. (2011). Adult medulloblastoma comprises three major molecular variants. Journal of Clinical Oncology, 29(19), 2717-2723.
157. Grammel, D., Warmuth-Metz, M., von Bueren, A. O., Kool, M., Pietsch, T., Kretzschmar, H. A., et al. (2012). Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathologica, 123(4), 601-614.
158. Wen, P. Y., & Kesari, S. (2008). Malignant gliomas in adults. The New England Journal of Medicine, 359(5), 492-507.
159. Gilbertson, R. J., & Ellison, D. W. (2008). The origins of medulloblastoma subtypes. Annual Review of Pathology, 3, 341-365.
160. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science, 321(5897), 1807-1812.
161. Parsons, D. W., Li, M., Zhang, X., Jones, S., Leary, R. J., Lin, J. C., et al. (2011). The genetic landscape of the childhood cancer medulloblastoma. Science, 331(6016), 435-439.
162. Hudson, T. J., Anderson, W., Artez, A., Barker, A. D., Bell, C., Bernabe, R. R., et al. (2010). International network of cancer genome projects. Nature, 464(7291), 993-998.
163. Johansson, F. K., Brodd, J., Eklof, C., Ferletta, M., Hesselager, G., Tiger, C. F., et al. (2004). Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proceedings of the National Academy of Sciences of the United States of America, 101(31), 11334-11337.
164. Johansson, F. K., Goransson, H., & Westermark, B. (2005). Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene, 24(24), 3896-3905.
165. Johansson Swartling, F. (2008). Identifying candidate genes involved in brain tumor formation. Upsala Journal of Medical Sciences, 113(1), 1-38.
166. Swartling, F. J., Ferletta, M., Kastemar, M., Weiss, W. A., & Westermark, B. (2009). Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene, 28(35), 3121-3131.
167. Phillips, J. J., Huillard, E., Robinson, A. E., Ward, A., Lum, D. H., Polley, M. Y., et al. (2012). Heparan sulfate sulfatase SULF2 regulates PDGFRalpha signaling and growth in human and mouse malignant glioma. The Journal of Clinical Investigation, 122(3), 911-922.
168. Tchougounova, E., Jiang, Y., Brasater, D., Lindberg, N., Kastemar, M., Asplund, A., et al. (2009). Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene, 28(12), 1537-1548.
169. Ferletta, M., Uhrbom, L., Olofsson, T., Ponten, F., & Westermark, B. (2007). Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B-induced gliomagenesis. Molecular Cancer Research, 5(9), 891-897.
170. Wolf, R. M., Draghi, N., Liang, X., Dai, C., Uhrbom, L., Eklof, C., et al. (2003). p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes & Development, 17(4), 476-487.
171. Wiesner, S. M., Decker, S. A., Larson, J. D., Ericson, K., Forster, C., Gallardo, J. L., et al. (2009). De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Research, 69(2), 431-439.
172. Collier, L. S., Adams, D. J., Hackett, C. S., Bendzick, L. E., Akagi, K., Davies, M. N., et al. (2009). Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Research, 69(21), 8429-8437.
173. Bender, A. M., Collier, L. S., Rodriguez, F. J., Tieu, C., Larson, J. D., Halder, C., et al. (2010). Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Research, 70(9), 3557-3565.
174. Dupuy, A. J., Akagi, K., Largaespada, D. A., Copeland, N. G., & Jenkins, N. A. (2005). Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature, 436(7048), 221-226.
175. Weissenberger, J., Steinbach, J. P., Malin, G., Spada, S., Rulicke, T., & Aguzzi, A. (1997). Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice. Oncogene, 14(17), 2005-2013.
176. Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H., & Sherr, C. J. (1999). Tumor spectrum in ARF-deficient mice. Cancer Research, 59(9), 2217-2222.
177. Jensen, N. A., Pedersen, K. M., Lihme, F., Rask, L., Nielsen, J. V., Rasmussen, T. E., et al. (2003). Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas. The Journal of Biological Chemistry, 278(10), 8300-8308.
178. Abel, T. W., Clark, C., Bierie, B., Chytil, A., Aakre, M., Gorska, A., et al. (2009). GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma. Molecular Cancer Research, 7(5), 645-653.
179. Shannon, P., Sabha, N., Lau, N., Kamnasaran, D., Gutmann, D. H., & Guha, A. (2005). Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model. The American Journal of Pathology, 167(3), 859-867.
180. Wei, Q., Clarke, L., Scheidenhelm, D. K., Qian, B., Tong, A., Sabha, N., et al. (2006). High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. Cancer Research, 66(15), 7429-7437.
181. Xiao, A., Wu, H., Pandolfi, P. P., Louis, D. N., & Van Dyke, T. (2002). Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell, 1(2), 157-168.
182. Uhrbom, L., Hesselager, G., Ostman, A., Nister, M., & Westermark, B. (2000). Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. International Journal of Cancer, 85(3), 398-406.
183. Dai, C., Lyustikman, Y., Shih, A., Hu, X., Fuller, G. N., Rosenblum, M., et al. (2005). The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats. Neoplasia, 7(4), 397-406.
184. Shih, A. H., Dai, C., Hu, X., Rosenblum, M. K., Koutcher, J. A., & Holland, E. C. (2004). Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Research, 64(14), 4783-4789.
185. Hu, X., Pandolfi, P. P., Li, Y., Koutcher, J. A., Rosenblum, M., & Holland, E. C. (2005). mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia, 7(4), 356-368.
186. Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A. J., et al. (2008). p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature, 455(7216), 1129-1133.
187. Gil-Perotin, S., Marin-Husstege, M., Li, J., Soriano-Navarro, M., Zindy, F., Roussel, M. F., et al. (2006). Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. The Journal of Neuroscience, 26(4), 1107-1116.
188. Uziel, T., Zindy, F., Xie, S., Lee, Y., Forget, A., Magdaleno, S., et al. (2005). The tumor suppressors Ink4c and p53 collaborate independently with patched to suppress medulloblastoma formation. Genes & Development, 19(22), 2656-2667.
189. Lee, Y., Miller, H. L., Russell, H. R., Boyd, K., Curran, T., & McKinnon, P. J. (2006). Patched2 modulates tumorigenesis in patched1 heterozygous mice. Cancer Research, 66(14), 6964-6971.
190. Ayrault, O., Zindy, F., Rehg, J., Sherr, C. J., & Roussel, M. F. (2009). Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma. Molecular Cancer Research, 7(1), 33-40.
191. Briggs, K. J., Corcoran-Schwartz, I. M., Zhang, W., Harcke, T., Devereux, W. L., Baylin, S. B., et al. (2008). Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes & Development, 22(6), 770-785.
192. Sutter, R., Shakhova, O., Bhagat, H., Behesti, H., Sutter, C., Penkar, S., et al. (2010). Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene, 29(12), 1845-1856.
193. Hatton, B. A., Villavicencio, E. H., Pritchard, J., LeBlanc, M., Hansen, S., Ulrich, M., et al. (2010). Notch signaling is not essential in sonic hedgehog-activated medulloblastoma. Oncogene, 29(26), 3865-3872.
194. McCall, T. D., Pedone, C. A., & Fults, D. W. (2007). Apoptosis suppression by somatic cell transfer of Bcl-2 promotes Sonic hedgehog-dependent medulloblastoma formation in mice. Cancer Research, 67(11), 5179-5185.
195. Frappart, P. O., Lee, Y., Lamont, J., & McKinnon, P. J. (2007). BRCA2 is required for neurogenesis and suppression of medulloblastoma. The EMBO Journal, 26(11), 2732-2742.
196. Rakic, P. (1972). Mode of cell migration to the superficial layers of fetal monkey neocortex. The Journal of Comparative Neurology, 145(1), 61-83.
197. Hatten, M. E. (1990). Riding the glial monorail: a common mechanism for glial-guided neuronal migration in different regions of the developing mammalian brain. Trends in Neurosciences, 13(5), 179-184.